Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Irinotecan × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 27 Pancreatic Neoplasms 12 Neuroblastoma 10 Stomach Neoplasms 9 Neoplasm Metastasis 9 Neoplasms 7 Rectal Neoplasms 5 Small Cell Lung Carcinoma 3 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Ovarian Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colonic Neoplasms 3 Breast Neoplasms 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Sarcoma 2 Recurrence 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Osteosarcoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumors 2 Adenocarcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Refractory Solid Tumors 1

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡